ArticleMicromachines2025
Hardware Accelerators for Cardiovascular Signal Processing: A System-on-Chip Perspective.
Article in Micromachines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Real-time 3D cardiac tissue implementation for arrhythmia detection and management.Frontiers in bioengineering and biotechnology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study presents a comprehensive systematic analysis, investigating hardware accelerators specifically designed for real-time cardiovascular signal processing, focusing mainly on Electrocardiogram (ECG), Photoplethysmogram (PPG), and blood pressure monitoring systems. Cardiovascular Diseases (CVDs) represent the world's leading cause of morbidity and mortality, creating an urgent demand for efficient and accurate diagnostic technologies. Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, we systematically analysed 59 research papers on this topic, published from 2014 to 2024, categorising them into three main categories: signal denoising, feature extraction, and decision support with Machine Learning (ML) or Deep Learning (DL). A comprehensive performance benchmarking across energy efficiency, processing speed, and clinical accuracy demonstrates that hybrid Field Programmable Gate Array (FPGA)-Application Specific Integrated Circuit (ASIC) architectures and specialised Artificial Intelligence (AI) on Edge accelerators represent the most promising solutions for next-generation CVD monitoring systems. The analysis identifies key technological gaps and proposes future research directions focused on developing ultra-low-power, clinically robust, and highly scalable physiological signal processing systems. The findings provide guidance for advancing hardware-accelerated cardiovascular diagnostics toward practical clinical deployment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.